Nov 8, 2024 | Billing, Concierge services, Cost Savings, HealthJoy, JOY, MedBen Connect, Mobile App, MSK, Precertification, Savings, Telemedicine
Clients who offer the MedBen Connect technology experience are seeing savings in a variety of ways. On average, 65% of members activate the mobile app, and 15% utilize its services bundle every month. Powered by HealthJoy, MedBen Connect transforms health care access...
Sep 3, 2024 | Biosimilars, Cost Savings, Drug costs, GLP-1s, Humira, Mounjaro, Ozempic, Rx Costs, Savings, Trulicity, Wegovy
Humira continued to be the costliest prescription drug for self-funded health plans in 2023 by a comfortable margin, according to a recent Milliman commercial drug trends review. Used to treat a variety of conditions from Crohn’s to rheumatoid arthritis and psoriatic...
Aug 29, 2024 | Artificial Intelligence, Cost Savings, HealthJoy, JOY, MedBen Connect, Mobile App, Savings
There’s been a lot of talk this political season about the importance of “joy.” Well, MedBen is all about joy… and we offer it in all caps, no less. “JOY” is an AI-powered virtual assistant available to users of MedBen Connect...
Aug 1, 2024 | Cost Savings, Debit Cards, Flexible spending accounts (FSAs), FSA Store, Health care costs, Health flexible spending account (FSA), Savings
Offering your plan members a flexible spending account (FSA) option is not only an effective way to help them lower their health care spend (qualified purchases are made using tax-free dollars), but by adding a MedBen debit card, it’s a convenient way to do it!...
Jul 22, 2024 | Alternative Reimbursement Strategies, Cost Savings, Direct-to-Employer Contracting, Preferred provider organization (PPO), Savings
A new survey on health and benefit strategies for 2025 finds that one-third of large employers will offer an “alternative medical plan” to steer employees to quality, cost-effective care. At MedBen, nearly half of our clients have implemented alternative...
Jul 5, 2024 | Biosimilars, Cost Savings, Humira, MedBen Rx, News, Rx Costs, Savings
The Food and Drug Administration is considering a change to its biosimilar policy that would greatly speed up their approval process – which, if enacted, would be a big win for MedBen Rx clients who are already reducing their prescription drug spend through...
